课题基金 / 基金详情

Regulation of anti-tumor T cell responses by Hippo pathway kinase Mst1

Regulation of anti-tumor T cell responses by Hippo pathway kinase Mst1
Hippo 通路激酶 Mst1 调节抗肿瘤 T 细胞反应
批准号：
458663
负责人：
Bouchard Antoine
金额：
$7.65万
依托单位：
Institut de recherches cliniques de Montral
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458663&lang=en
关键词：
Anti-Tumor T Cell Immunity Cd8 T Stem-Cell Memory (Tscm) Flow Cytometry And Phosphoflow Hippo Signaling Immune Checkpoint Blockade Immunotherapy Melanoma Tumor Transplantation Model Single-Cell Rna Sequencing T Regulatory Cells (Tregs) Wnt Signal

项目摘要

项目成果

相关文献

中文摘要
翻译
在标准癌症治疗如放疗和化疗失败后，替代治疗对治愈癌症至关重要。癌症免疫疗法，这是基于增加免疫系统的能力，以对抗癌症，已成为一个承诺，
英文摘要
Upon failure of standard cancer treatments such as radiotherapy and chemotherapy, alternative treatments are essential to cure cancer. Cancer immunotherapy, which is based on increasing the ability of the immune system to fight cancer, has become a promis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文